femasys(FEMY) - 2024 Q1 - Quarterly Results

Exhibit 99.1 • Company announced positive topline data from pivotal trial for FDA-cleared FemaSeed® for the treatment of infertility. • Company announced the first in-office commercial procedure with FDA-cleared FemaSeed infertility solution at a former investigative site. • Appointed Richard Spector as Chief Commercial Officer. • Initiated enrollment in pivotal trial (NCT05977751) of our permanent birth control candidate FemBloc at two academic sites, for a total of six active sites, the maximum permitted ...